Clinical trial of comparing the effects of platelet-rich plasma gel on wound healing harvesting grafts in burn patients

Evaluation the effect of Plasma Rich Platelet gel on the rate of donor site wound healing in burn patients :Triple-blind clinical trial.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017030716148N4

Enrollment

Registered

2017-05-20

Start date

2015-07-07

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: burn. Condition 2: burn. Burn of second degree, body region unspecified Burn of third degree, body region unspecified

Interventions

Intervention 1: Intervention group: the use of platelet-rich plasma gel on skin graft harvest site and then using of standard dressing. Intervention 2: Control group: the use of standard dressing on s

Treatment - Drugs

Treatment - Other

Intervention group: the use of platelet-rich plasma gel on skin graft harvest site and then using of standard dressing

Control group: the use of standard dressing on skin graft harvest site

Eligibility

Sex/Gender

All

Age

15 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Aged between 15 and 60 years of age? autologous skin grafts to repair burns require surgery? having informed consent and willingness to participate in the plan. Exclusion criteria: To continue to cooperate dissatisfied for any reason and at any stage of the research? lack of time set for review? an underlying disease such as connective tissue disease, diabetes, cancer, malnutrition, sepsis and .... ?platelet 100000 or hemoglobin below 10 age younger than 15 and older than 60 years? infected or inflamed area harvested skin grafts from any cause? any manipulation on the wound harvest skin grafts? use of systemic corticosteroids 2 weeks ago? the use of nonprescription drugs or medication on the skin graft harvest? NSAID consumption up to 72 hours in advance? hemodynamic disorders.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
The extent of epithelialization. Timepoint: Day 10. Method of measurement: Morphologhy.;The amount of granulation. Timepoint: Day 10. Method of measurement: Morphology.;The amount of pigmentation. Timepoint: Day 30. Method of measurement: Morphology.;The amount of surface vascularity. Timepoint: Day 30. Method of measurement: Morphology.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSajad Kazemi

Sabzevar University of Medical Sciences

sajad_1370@yahoo.com+98 45 3245 1793

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026